PMcardio receives FDA Breakthrough Device Designation — read the full story

PM Magazine

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.

Editor's Choice

Winners+of+AHA's+Health+Tech+Competition+2024

Powerful Medical Wins Best Science Pitch and Overall Winner at AHA Health Tech Competition 2024

Timothy D. Henry, MD joins Powerful Medical's US Scientific board

Timothy D. Henry, MD Joins Powerful Medical’s US Scientific Advisory Board Amidst Entry to the US Market

Jolimont Hospital Helora

Jolimont Hospital in Belgium Implements PMcardio AI to Detect Acute Myocardial Infarction

Dr. Joseph Banno

Dr. Banno Pins Down Subtle STEMI Case Using PMcardio’s OMI AI Model

This case highlighted the limitations of traditional diagnostic methods and led Dr. Banno to explore innovative solutions for cardiac care. This exploration introduced him to the PMcardio tool, an AI-powered clinical decision support system for ECG interpretation
Dr. Christopher R. Schmelzer, MD

Dr. Schmelzer’s Turning Point: How a Severe Chest Pain Case Inspired PMcardio Adoption

The case of a 76-year-old patient with severe chest pain prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to discover the PMcardio OMI AI model.

Stay on the pulse with our newsletter

Your submission was successful